Results 51 to 60 of about 23,012 (218)

Proposal of a Vaccination Needs Index to Prioritise Municipal Interventions in Brazil

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Addressing population health needs requires integrating indicators expressed on non‐comparable scales, particularly for vaccination, a cornerstone of public health. Objective To propose and implement a Vaccination Needs Index based on national administrative data on tracer vaccines for children to support the prioritisation of Brazilian ...
Fredi Alexander Diaz‐Quijano   +4 more
wiley   +1 more source

Maternal predictors of timeliness & uptake of Measles, Mumps & Rubella vaccine: A birth cohort study [PDF]

open access: gold, 2023
Helen Skirrow   +6 more
openalex   +1 more source

Vaccine Incentives Harm Intrinsic Motivation: Evidence From a Priming Experiment

open access: yesHealth Economics, Volume 35, Issue 2, Page 312-331, February 2026.
ABSTRACT Monetary incentives for vaccination may undermine intrinsic motivation, but evidence on this effect remains scarce. We conducted an experiment among 513 vaccine‐hesitant adults to test whether priming individuals with a monetary incentive reduces their willingness to vaccinate against COVID‐19.
Johnny Huynh, Corey Jacinto, James Huynh
wiley   +1 more source

Humoral immunity to mumps in a highly vaccinated population in Taiwan

open access: yesJournal of Microbiology, Immunology and Infection, 2019
Background: A resurgence of mumps was noted recently and outbreaks were increasingly reported in populations with high vaccine coverage. We aimed to evaluate the seroprevalence to mumps in Taiwan, where a two-dose childhood mumps-containing vaccine ...
Yu-Huai Ho   +6 more
doaj   +1 more source

Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors

open access: yesInternational Journal of Dermatology, Volume 65, Issue 2, Page 230-237, February 2026.
Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors. ABSTRACT Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine ...
Mariano Ara‐Martín   +5 more
wiley   +1 more source

New‐onset autoimmune disease following SARS‐CoV‐2 infection and mRNA vaccination in Norway: A retrospective cohort study

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 271-282, February 2026.
Abstract Background Studies suggest an increase in autoimmune diseases following SARS‐CoV‐2 infection and/or COVID‐19‐vaccination. We aimed to describe possible associations in Norway. Methods We used information from the emergency preparedness register for COVID‐19, BeredtC19, for all residents aged 18–64 (N = 3,450,080).
Håkon Bøås   +4 more
wiley   +1 more source

Comparative Efficacy and Safety of Intralesional MMR Vaccine and Vitamin D3 in Managing Nongenital Warts: A Systematic Review and Meta‐Analysis

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Cutaneous warts are common benign lesions caused by human papillomavirus and often resist conventional treatments. Intralesional immunotherapy with measles–mumps–rubella (MMR) vaccine or vitamin D3 has emerged as an alternative, but their comparative efficacy and safety remain unclear.
Rahul Balach   +9 more
wiley   +1 more source

Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting

open access: yesR&D Management, Volume 56, Issue 1, Page 71-87, January 2026.
ABSTRACT Open science literature scrutinizes how organizations provide access to knowledge. Yet, much less is known about how organizations pursuing open science for societal impact anticipate knowledge applicability—that shared knowledge is reusable for other organizations and individuals, and enables open social innovation.
Konstantin Hondros   +3 more
wiley   +1 more source

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

open access: yesEmerging Infectious Diseases, 2013
Although the measles-mumps-rubella (MMR) vaccine is not recommended for mumps postexposure prophylaxis (PEP), data on its effectiveness are limited. During the 2009–2010 mumps outbreak in the northeastern United States, we assessed effectiveness of PEP ...
Amy Parker Fiebelkorn   +4 more
doaj   +1 more source

Silica Nanoparticles as Multifunctional Platforms for Vaccine Delivery and Immune Modulation in Infectious Diseases

open access: yesAdvanced NanoBiomed Research, Volume 5, Issue 12, December 2025.
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy